Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
A randomized controlled trial of stepped treatment to reduce unhealthy alcohol use in patients with chronic liver disease.
Journal: Hepatology (Baltimore, Md.)
Published: January 17, 2026
Resolving fibrosis by stimulating HSC-dependent extracellular matrix degradation.
Journal: Science translational medicine
Published: August 27, 2025
Clinical Outcomes Following a Patient-Centered Educational Intervention on Steatotic Liver Disease: A Comparison of Patients With and Without Diabetes.
Journal: Gastro hep advances
Published: February 07, 2025
Skin Cancer Diagnosis by Lesion, Physician, and Examination Type: A Systematic Review and Meta-Analysis.
Journal: JAMA dermatology
Published: November 13, 2024
Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease.
Journal: Alimentary pharmacology & therapeutics
Published: September 12, 2024
Steatotic Liver Disease Education Enhances Knowledge and Confidence to Adhere to Provider Recommendations in Diverse and Vulnerable Populations.
Journal: Gastro hep advances
Published: June 28, 2024
Integrins in biliary injury and fibrosis.
Journal: Current opinion in gastroenterology
Published: January 08, 2024
AMPK stimulation inhibits YAP/TAZ signaling to ameliorate hepatic fibrosis.
Journal: Scientific reports
Published: December 09, 2023
Problematic alcohol use and its impact on liver disease quality of life in a multicenter study of patients with cirrhosis.
Journal: Hepatology communications
Published: November 30, 2023
Telehepatology Use and Satisfaction Among Vulnerable Cirrhosis Patients Across Three Healthcare Systems in the Coronavirus Disease Pandemic Era.
Journal: Gastro hep advances
Published: October 04, 2023
Screening the human druggable genome identifies ABHD17B as an anti-fibrotic target in hepatic stellate cells.
Journal: Nature communications
Published: August 29, 2023
Last Updated: 09/26/2026